Impact of age on outcomes after initial therapy with chemotherapy and different chemoimmunotherapy regimens in patients with chronic lymphocytic leukemia: Results of sequential cancer and leukemia group B studies Academic Article uri icon

Overview

MeSH Major

  • Aging
  • Antineoplastic Combined Chemotherapy Protocols
  • Leukemia, Lymphocytic, Chronic, B-Cell

abstract

  • These data support the use of chlorambucil as an acceptable treatment for many older patients with CLL and suggest rituximab is beneficial regardless of age. These findings bear relevance to both routine care of CLL patients 70 years and older and also future clinical trials in this population.

publication date

  • February 2013

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3731920

Digital Object Identifier (DOI)

  • 10.1200/JCO.2011.41.5646

PubMed ID

  • 23233702

Additional Document Info

start page

  • 440

end page

  • 7

volume

  • 31

number

  • 4